Duke Royalty Limited (DUKE)

Sector:

Financials

Index:

FTSE AIM All-Share

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

43.50p
   
  • Change Today:
    -0.30p
  • 52 Week High: 48.10
  • 52 Week Low: 38.00
  • Currency: UK Pounds
  • Shares Issued: 199.87m
  • Volume: 166,692
  • Market Cap: £86.94m
  • Beta: 0.00

Duke Royalty agrees healthcare royalty financing deal with Marsh McLennan

By Oliver Haill

Date: Monday 07 Sep 2015

LONDON (ShareCast) - (ShareCast News) - Royalty financing outfit Duke Royalty has signed an agreement with the consultancy arm of US insurance broking giant Marsh & McLennan to focus on healthcare royalty transactions in Europe.
Oliver Wyman, a management consultancy arm of Marsh & McLennan, will offer royalty financing provided by Duke, which in June changed its name from Praetorian Resources and its investment strategy from natural resources to this newer alternative to debt financing.

Duke's directors, which now include former Canaccord banker Neil Johnson as chief executive of Duke Royalty, bring expertise of the North American market for royalty financing, where companies pay back loans using a percentage of cash flow or revenue.

The sector is worth around $30bn in North America but in Europe has yet to take off.

Johnson said: "North America has built a number of highly successful and significant sized royalty companies in both the private and listed arenas. The Duke Royalty and Oliver Wyman collaboration will provide this progressive and compelling financing structure to the global healthcare industry."

The collaboration would leverage Oliver Wyman's presence across 26 countries and with 200-plus professionals in its healthcare business, to initially focus on offering European healthcare companies a financing alternative via the US company's trusted name.

Under the terms of the collaboration, Oliver Wyman will identify, analyse and assist in the acquisition of royalty interests for regulatory-approved, patent-protected ethical pharmaceutical and other healthcare products.

Johnson said Duke looked forward to providing investors with "predictable revenues and a stable dividend".

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

DUKE Market Data

Currency UK Pounds
Share Price 43.50p
Change Today -0.30p
% Change -0.68 %
52 Week High 48.10
52 Week Low 38.00
Volume 166,692
Shares Issued 199.87m
Market Cap £86.94m
Beta 0.00

DUKE Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.78% below the market average51.78% below the market average51.78% below the market average51.78% below the market average51.78% below the market average
7.25% below the sector average7.25% below the sector average7.25% below the sector average7.25% below the sector average7.25% below the sector average
Price Trend
38.58% below the market average38.58% below the market average38.58% below the market average38.58% below the market average38.58% below the market average
45.81% above the sector average45.81% above the sector average45.81% above the sector average45.81% above the sector average45.81% above the sector average
Income
Market averageMarket averageMarket averageMarket averageMarket average
42.50% above the sector average42.50% above the sector average42.50% above the sector average42.50% above the sector average42.50% above the sector average
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

DUKE Dividends

  Latest Previous
  Q1 Q4
Ex-Div 04-Apr-19 27-Dec-18
Paid 17-Apr-19 12-Jan-19
Amount 0.70p 0.70p

Trades for 21-Mar-2019

Time Volume / Share Price
14:04 10,000 @ 43.65p
13:55 7,000 @ 43.70p
13:48 1,250 @ 43.25p
12:35 22,635 @ 43.85p
11:52 22,805 @ 43.85p

DUKE Key Personnel

CEO Neil A Johnson

Top of Page